[1]
Wewer UM, Engvall E. Merosin/laminin-2 and muscular dystrophy. Neuromuscular disorders : NMD. 1996 Dec:6(6):409-18
[PubMed PMID: 9027848]
[2]
Yurchenco PD, McKee KK, Reinhard JR, Rüegg MA. Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies. Matrix biology : journal of the International Society for Matrix Biology. 2018 Oct:71-72():174-187. doi: 10.1016/j.matbio.2017.11.009. Epub 2017 Nov 27
[PubMed PMID: 29191403]
[3]
Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, Asplund A, Sjöstedt E, Lundberg E, Szigyarto CA, Skogs M, Takanen JO, Berling H, Tegel H, Mulder J, Nilsson P, Schwenk JM, Lindskog C, Danielsson F, Mardinoglu A, Sivertsson A, von Feilitzen K, Forsberg M, Zwahlen M, Olsson I, Navani S, Huss M, Nielsen J, Ponten F, Uhlén M. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular & cellular proteomics : MCP. 2014 Feb:13(2):397-406. doi: 10.1074/mcp.M113.035600. Epub 2013 Dec 5
[PubMed PMID: 24309898]
[4]
Villanova M, Malandrini A, Sabatelli P, Sewry CA, Toti P, Torelli S, Six J, Scarfó G, Palma L, Muntoni F, Squarzoni S, Tosi P, Maraldi NM, Guazzi GC. Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study. Acta neuropathologica. 1997 Dec:94(6):567-71
[PubMed PMID: 9444358]
[5]
Allamand V, Guicheney P. Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for alpha2 chain of laminin). European journal of human genetics : EJHG. 2002 Feb:10(2):91-4
[PubMed PMID: 11938437]
[6]
Pinkel D, Segraves R, Sudar D, Clark S, Poole I, Kowbel D, Collins C, Kuo WL, Chen C, Zhai Y, Dairkee SH, Ljung BM, Gray JW, Albertson DG. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature genetics. 1998 Oct:20(2):207-11
[PubMed PMID: 9771718]
Level 2 (mid-level) evidence
[7]
Behjati S, Tarpey PS. What is next generation sequencing? Archives of disease in childhood. Education and practice edition. 2013 Dec:98(6):236-8. doi: 10.1136/archdischild-2013-304340. Epub 2013 Aug 28
[PubMed PMID: 23986538]
[8]
Smith DR, Quinlan AR, Peckham HE, Makowsky K, Tao W, Woolf B, Shen L, Donahue WF, Tusneem N, Stromberg MP, Stewart DA, Zhang L, Ranade SS, Warner JB, Lee CC, Coleman BE, Zhang Z, McLaughlin SF, Malek JA, Sorenson JM, Blanchard AP, Chapman J, Hillman D, Chen F, Rokhsar DS, McKernan KJ, Jeffries TW, Marth GT, Richardson PM. Rapid whole-genome mutational profiling using next-generation sequencing technologies. Genome research. 2008 Oct:18(10):1638-42. doi: 10.1101/gr.077776.108. Epub 2008 Sep 4
[PubMed PMID: 18775913]
[9]
Shendure J, Ji H. Next-generation DNA sequencing. Nature biotechnology. 2008 Oct:26(10):1135-45. doi: 10.1038/nbt1486. Epub
[PubMed PMID: 18846087]
[10]
Li Z, Zeppa JJ, Hancock MA, McCormick JK, Doherty TM, Hendy GN, Madrenas J. Staphylococcal Superantigens Use LAMA2 as a Coreceptor To Activate T Cells. Journal of immunology (Baltimore, Md. : 1950). 2018 Feb 15:200(4):1471-1479. doi: 10.4049/jimmunol.1701212. Epub 2018 Jan 15
[PubMed PMID: 29335257]
[11]
Oliveira J, Gruber A, Cardoso M, Taipa R, Fineza I, Gonçalves A, Laner A, Winder TL, Schroeder J, Rath J, Oliveira ME, Vieira E, Sousa AP, Vieira JP, Lourenço T, Almendra L, Negrão L, Santos M, Melo-Pires M, Coelho T, den Dunnen JT, Santos R, Sousa M. LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes. Human mutation. 2018 Oct:39(10):1314-1337. doi: 10.1002/humu.23599. Epub 2018 Aug 10
[PubMed PMID: 30055037]
[12]
Hashemi-Gorji F, Yassaee VR, Dashti P, Miryounesi M. Novel LAMA2 Gene Mutations Associated with Merosin-Deficient Congenital Muscular Dystrophy. Iranian biomedical journal. 2018 Nov:22(6):408-14
[PubMed PMID: 29707938]
[13]
He Z, Luo X, Liang L, Li P, Li D, Zhe M. Merosin-deficient congenital muscular dystrophy type 1A: A case report. Experimental and therapeutic medicine. 2013 Nov:6(5):1233-1236
[PubMed PMID: 24223650]
Level 3 (low-level) evidence
[14]
Fabris A, Bruschi M, Santucci L, Candiano G, Granata S, Dalla Gassa A, Antonucci N, Petretto A, Ghiggeri GM, Gambaro G, Lupo A, Zaza G. Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. Kidney international. 2017 Feb:91(2):459-468. doi: 10.1016/j.kint.2016.09.035. Epub 2016 Dec 1
[PubMed PMID: 27914711]